Showing results (251-260 of 317) with videos related to

Sort By:
Pageof 32
Oncogene|February 8, 2006
Mutually exclusive NRASQ61R and BRAFV600E mutations at the single-cell level in the same human melanomaM Sensi, G Nicolini, C Petti, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|September 1, 1996
Differences in frequency distribution of HLA-A2 subtypes between North American and Italian white melanoma patients: relevance for epitope specific vaccination protocolsM A Player, K C Barracchini, T B Simonis, et al.
Blood|September 1, 1993
Occurrence of resistance to retinoic acid in the acute promyelocytic leukemia cell line NB4 is associated with altered expression of the pml/RAR alpha proteinS Dermime, F Grignani, M Clerici, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1998
Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killingL Rivoltini, M Radrizzani, P Accornero, et al.
The Journal of Experimental Medicine|January 1, 1995
Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytesC Castelli, W J Storkus, M J Maeurer, et al.
Tissue Antigens|August 1, 1982
Strong association between an HLA-DR antigen and thyroid carcinomaN Panza, L Del Vecchio, M Maio, et al.
Melanoma Research|October 1, 1995
Anti-tyrosinase antibodies participate in the immune response to vaccination with anti-idiotypic antibodies mimicking the high-molecular-weight melanoma-associated antigenE Baharav, O Merimsky, M Altomonte, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 9, 1998
Microsomal metabolism of delavirdine: evidence for mechanism-based inactivation of human cytochrome P450 3AR L Voorman, S M Maio, N A Payne, et al.
American Journal of Clinical Oncology|December 1, 1996
Melanoma-associated hypopigmentation: where are the antibodies?O Merimsky, Y Shoenfeld, E Baharav, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 30, 1999
Prolonged upregulation of the expression of HLA class I antigens and costimulatory molecules on melanoma cells treated with 5-aza-2'-deoxycytidine (5-AZA-CdR)S Coral, L Sigalotti, A Gasparollo, et al.
Pageof 32